Shaanxi Kaishi Biotechnology Co., Ltd

English

Phone:
15537834455

Select Language
English
Products> Enzyme Preparation> Pharmaceutical Enzymes> Methotrexate 98% Oncology API Supply
Methotrexate 98% Oncology API Supply

Methotrexate 98% Oncology API Supply

  • $40

    1-199 Others

  • $30

    200-499 Others

  • $20

    ≥500 Others

Share:
Product Attributes

Product Description

Product Overview

Methotrexate 98% is a high-purity pharmaceutical active pharmaceutical ingredient (API) widely used in oncology, autoimmune disease therapy, and advanced drug formulation development. As a folate antagonist, it inhibits dihydrofolate reductase activity and plays a central role in chemotherapy and immunosuppressive treatment systems.

In the global pharmaceutical supply chain, Methotrexate is a core compound for GMP-compliant manufacturing, Supplement Contract Manufacturing, and CDMO production. It is widely used in injectable, oral, and research-grade pharmaceutical formulations.

Content Note: Prepared by our technical team based on peer-reviewed scientific literature. This content is intended for industrial and research use only and complies with FDA/EFSA communication guidelines. Last reviewed: June 2026
According to a study in The New England Journal of Medicine (1988), methotrexate demonstrated significant clinical efficacy in rheumatoid arthritis treatment as a disease-modifying antirheumatic drug (DMARD).
According to a study in Journal of Clinical Oncology (2001), methotrexate-based chemotherapy regimens showed measurable therapeutic activity in selected oncology applications, including lymphoma and solid tumor protocols.

Key Ingredients & Specifications

Methotrexate 98% is manufactured under strict GMP-controlled environments to ensure high purity, batch consistency, and pharmaceutical-grade compliance for global distribution.

Parameter Specification
Active Ingredient Methotrexate
Purity ≥ 98%
Appearance Yellow to orange crystalline powder
Test Method HPLC
Form API powder / pharmaceutical intermediate
Storage Condition 2–8°C, sealed and light-protected

Differentiation Content – Manufacturing Excellence

The quality of Methotrexate 98% depends on synthesis route control, purification technology, and GMP-certified production systems. Advanced manufacturing ensures consistent performance and regulatory compliance.

Process Stage Quality Impact
Controlled chemical synthesis Ensures structural integrity and potency consistency
Multi-stage purification process Reduces impurities and improves safety profile
Controlled drying and packaging Enhances stability and shelf-life performance

Comparison with Key Pharmaceutical APIs

API Mechanism Application Area
Methotrexate Folate metabolism inhibition Autoimmune diseases, oncology treatment
Docetaxel Microtubule stabilization Solid tumor chemotherapy
Cyclophosphamide DNA alkylation Broad-spectrum cancer therapy

Applications & Benefits

Methotrexate 98% is widely used in pharmaceutical manufacturing and clinical drug development for oncology and immunology applications.

  • Oncology chemotherapy drug production
  • Autoimmune disease treatment formulation
  • Rheumatoid arthritis medication development
  • Clinical trial active pharmaceutical ingredient supply
  • GMP contract manufacturing (CMO/CDMO)

It is also applied in research contexts involving Plant Extracts , Standardized Extracts, Herbal Extracts , Nutritional Ingredients, and Antioxidants for pharmaceutical innovation and formulation science.

Core Keyword Integration

Why Choose Us – Quality & OEM Capability

We supply Methotrexate 98% under strict GMP-certified systems with full regulatory support for global pharmaceutical markets.

  • Certifications: GMP, ISO, HACCP
  • OEM Services: Private label, formulation support, CDMO collaboration
  • Dosage Forms: API powder and injectable intermediates
  • MOQ: Flexible for R&D and bulk procurement
  • Quality Control: HPLC, NMR, microbial testing

Frequently Asked Questions

What is Methotrexate 98% used for?

It is used as an active pharmaceutical ingredient in cancer therapy and autoimmune disease treatment.

Is Methotrexate suitable for injectable formulations?

Yes, it is commonly formulated into sterile injectable and oral dosage forms under GMP standards.

What is the purity standard of Methotrexate API?

The standard purity is ≥98%, confirmed by HPLC analytical testing methods.

How should Methotrexate be stored?

It should be stored at 2–8°C in a sealed, light-protected environment to maintain stability.

Do you support OEM or CDMO services?

Yes, we provide OEM, private label, and contract manufacturing services for global pharmaceutical clients.

44
Packaging & Delivery

Packaging & Delivery

The file is encrypted. Please fill in the following information to continue accessing it

GET IN TOUCH
If you have any questions our products or services,feel free to reach out to us.Provide unique experiences for everyone involved with a brand.we've got preferential price and best-quality products for you.
Please fill in the information
* Please fill in your e-mail
* Please fill in the content
Products> Enzyme Preparation> Pharmaceutical Enzymes> Methotrexate 98% Oncology API Supply
  • Contact Us

  • Mobile Phone: 15537834455
  • Email: sales01@kaishibio.com
  • Address: No. 11206, 12th Floor, Unit 1, Building 15, Zhongmao Plaza, West of Nanguanzheng Street, Beilin District, Xian, Shaanxi China
  • Website: https://www.kaishibio.com
  • Send Inquiry

Copyright © 2026 Shaanxi Kaishi Biotechnology Co., Ltd All rights reserved. Privacy Policy

Send Inquiry
*
*

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send